Tysabri Injection contains humanized monoclonal antibody which is indicated for treatment of Crohn's disease & multiple sclerosis. It is administered via intravenous route by a trained professional and assures superior effectiveness. This injection is said to have elimination half life of 11 +/- 4 days with targeted mode of action. It is said to have ability to inhibit attachment of inflammatory immune cells thus improves quality of life in people with multiple sclerosis. Tysabri Injection offered by us is available at highly competitive rates in bulk for our respected customers.
Cash in Advance (CID), Cash Advance (CA)
500 Per Month
Main Export Market(s)
Africa, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Main Domestic Market
Other Products in 'Pharmaceutical Injection' You May Like